Consistently, many studies have demonstrated that the activation of the cell cycle, PI3K-AKT, MTORC1, NOTCH, and MYC pathways enhances the progression of glioma (Parmigiani et al., 2020; Colardo and Segatto, 2021; Hajj et al., 2021). Here, AKT1 is linked to glioma.